3 | SEC Filings Hub

Filing metadata

Accession number: 0000950170-24-066826
Form type: Form 3
Filer: Evoke Pharma Inc
CIK: CIK 1403708
Filed: May 30, 2024
Reporting period: May 22, 2024
Description: Initial ownership

Documents

0000950170-24-066826-index.htm

Complete submission

0000950170-24-066826.txt

directory listing

Filed by

Evoke Pharma Inc